ARCHIVES

In Phase II Study, NKTR-102 Shows Objective Response

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

NCI Programs: Seven Win Awards For Cancer Genetics Network, Informatics

July 31, 1998

OMB To Seek Rescission In ’79 Appropriation For NIH; NCI Cut Would BE $29 Million; FY 1980 Budget Request Will Be $912.7 Million

December 8, 1978

Lung Cancer Prevention Diet Study Concept Tabled By DCPC Board

February 8, 1985

NCA Asks HHS To Exempt From DRG Peer Reviewed Institutions With At Least 25 Protocol Patients

August 12, 1983

Digital Microscope Blood Test Identifies Circulating Tumor Cells

February 24, 2012